Showing results (2161-2170 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|August 28, 2013
The road not taken: transferability issues in multinational trialsPepijn Vemer, Maureen P M H Rutten-van Mölken
Pharmacoeconomics|September 17, 2013
Projecting expenditure on medicines in the UK NHSPhill O'Neill, Jorge Mestre-Ferrandiz, Ruth Puig-Peiro, et al.
Pharmacoeconomics|August 3, 2013
Costs of Parkinson's disease in a privately insured populationScott J Johnson, Anna Kaltenboeck, Melissa Diener, et al.
Pharmacoeconomics|April 10, 2013
Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemiaMichael J Sorich, Michael D Wiese, Rebekah L O'Shea, et al.
Pharmacoeconomics|April 11, 2013
Disutility of illness for caregivers and families: a systematic review of the literatureEve Wittenberg, Lisa A Prosser
Pharmacoeconomics|June 29, 2013
Good practice guidelines for the use of statistical regression models in economic evaluationsBen Kearns, Roberta Ara, Allan Wailoo, et al.
Pharmacoeconomics|April 26, 2013
A comparative analysis of models used to evaluate the cost-effectiveness of dabigatran versus warfarin for the prevention of stroke in atrial fibrillationSonja V Sorensen, Siyang Peng, Brigitta U Monz, et al.
Pharmacoeconomics|April 27, 2013
Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United StatesKit N Simpson, Pamela P Pei, Jörgen Möller, et al.
Pharmacoeconomics|April 27, 2013
Transferability of indirect cost of chronic disease: a systematic review and meta-analysisFei-Li Zhao, Feng Xie, Hao Hu, et al.
Pharmacoeconomics|July 6, 2013
Time trends and determinants of pharmaceutical expenditure in China (1990-2009)Lizheng Shi, Heidi Y Yang, Gang Cheng, et al.
Pageof 336